Loading organizations...
Key people at Entourage Effect Capital.
Entourage Effect Capital was founded in 2014 by Matt Hawkins (Founder & Managing Partner) and Andrew Sturner (Co-Founder & Managing Partner) and Dov Szapiro (Co-Founder I Co-Managing Partner).
Entourage Effect Capital is an investment firm dedicated to the cannabis industry, deploying capital into businesses poised for significant expansion. The company manages various funds, including its current Fund III, which strategically targets growth-stage companies. They emphasize a hands-on approach, leveraging their collective experience, industry networks, and proprietary processes to support portfolio companies and create intrinsic value within the rapidly evolving cannabis market.
The firm was co-founded in 2014 by Matthew Hawkins, Dov Szapiro, and Andy Sturner, initially operating as Cresco Capital Partners. Matthew Hawkins brought over two decades of private equity experience, having established multiple alternative investment firms, and quickly became recognized as a leading cannabis investor. Dov Szapiro’s background includes extensive senior executive and private equity roles across various industries, while Andy Sturner contributed his 30 years in law, entrepreneurship, and angel/venture investing. This combined pedigree allowed them to identify and capitalize on the nascent opportunities within the cannabis sector.
Entourage Effect Capital primarily serves cannabis companies seeking strategic investment and operational support to scale their businesses effectively. Their vision is to transform these companies into industry leaders, continually applying their investment theses across the sector's history. The firm aims to be a highly valuable partner to its founders, contributing significantly beyond just capital as the industry moves towards broader acceptance and federal reform.
Entourage Effect Capital was founded in 2014 by Matt Hawkins (Founder & Managing Partner) and Andrew Sturner (Co-Founder & Managing Partner) and Dov Szapiro (Co-Founder I Co-Managing Partner).
Key people at Entourage Effect Capital.
Entourage Effect Capital has 4 tracked investments across 4 companies. The latest tracked deal is $9.0M Series B in Mr. Moxey's Mints in July 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 17, 2023 | Mr. Moxey's Mints | $9.0M Series B | Greenaxs Capital, Tiby Erdely | AFI Capital Partners |
| Jun 1, 2022 | BioLumic | $14.0M Series B | OurCrowd | Alumni Ventures, Foundry Group, General Atlantic, H.I.G. Capital, Madrona Venture Group, GIL Penchina, Sapphire Ventures, Chaim Meir Tessler, Will Herman, Arcview Ventures, Aspire NZ, Booster Innovation Fund, Canopy Rivers, Finistere Ventures, Flatiron Venture Partners, Icehouse Ventures, MIG Nominee NO 1 Limited, Norwind Capital, Prithvi Ventures, Rabo Ventures, Virtu Capital |
| Oct 1, 2021 | Cellibre | $12.0M Series A | Merida Capital Partners | B Capital Group, Mechanism Capital, NEW Form Capital, Prithvi Ventures, Scott Gordon, Delta Emerald Ventures, Flatiron Venture Partners, L2 Ventures |
| Sep 30, 2019 | PathogenDx | $7.5M Series B | Entourage Effect Capital | Altitude Investment Management, Arcadian Investment Partners, Flatiron Venture Partners, Panther Opportunity Fund, Salveo Capital |